"Long-Acting Buprenorphine Implant Effective for Opioid Dependence"
Phase 3 study results presented at the American Society of Addiction Medicine annual conference indicated efficacy of Probuphine, a 6-month subdermal buprenorphine implant, for long-term maintenance treatment of opioid addiction. “This was the first head-to-head comparison study of Probuphine and sublingual buprenorphine, demonstrating the efficacy of a long acting 6-month buprenorphine implant,” study researcher Richard Rosenthal, MD, medical director of Addiction Psychiatry for the Mount Sinai Behavioral Health System, said. Learn more.
CBD Reduces Craving and Anxiety in People With Heroin Use Disorder
May 21, 2019 View All Press Releases